biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Nice volume on E trade today

<< Previous

Bullboard Posts

Next >>

Comment by Druks177on Jul 02, 2021 12:18pm

158 Views

Post# 33482229

RE:RE:Nice volume on E trade today

I'll I know is you have a few loose screws to be selling in the next few days. Too much potential in the next 12months to be giving away shares in the 30's and 40's when our marketcap sub $40mil

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China